Abstract. The present study was conducted to explore renal progenitor-like cells that are actively engaged in tubular regeneration after injury. For addressing this issue, the existence of label-retaining cells (LRC; slow-cycling cells) in normal rat kidneys by in vivo bromodeoxyuridine (BrdU) labeling was examined. LRC were scattering among renal epithelial tubular cells of normal rat kidneys. During the recovery after renal ischemia, LRC underwent cell division and most of them became positive for proliferating cell nuclear antigen. In contrast, proliferating cell nuclear antigen-positive but BrdU-negative tubular cells were rarely observed, suggesting that cells proliferating during tubular regeneration are essentially derived from LRC. At an early phase of tubular regeneration, descen-
progenitor-like cells that are actively engaged in tubular regeneration after injury. For addressing this issue, the existence of label-retaining cells (LRC; slow-cycling cells) in normal rat kidneys by in vivo bromodeoxyuridine (BrdU) labeling was examined. LRC were scattering among renal epithelial tubular cells of normal rat kidneys. During the recovery after renal ischemia, LRC underwent cell division and most of them became positive for proliferating cell nuclear antigen. In contrast, proliferating cell nuclear antigen-positive but BrdU-negative tubular cells were rarely observed, suggesting that cells proliferating during tubular regeneration are essentially derived from LRC. At an early phase of tubular regeneration, descendants of LRC expressed a mesenchymal marker, vimentin, and eventually became positive for an epithelial marker, E-cadherin, after multiple cell divisions. These findings suggested that LRC function as a source of regenerating cells to replace injured cells. Collectively, it was concluded that LRC are renal progenitor-like tubular cells that provide regenerating cells, which actively proliferate and eventually differentiate into epithelial cell, during tubular regeneration. It may be possible to regenerate renal tubules in vivo through the activation of LRC.
In general, stem cells have a slow turnover and display minimal physiologic differentiation. As early descendants of stem cells, transit-amplifying (TA) cells retain significant growth capacity while acquiring differentiated functions. TA cells eventually become incapable of proliferation and enter a terminally differentiated state (1) (2) (3) (4) . To conserve growth potential and to prevent genetic injury during mitosis, stem cells are thought to cycle slowly and are recruited only as demanded by tissue turnover. Therefore, much of the increase in cell number in the steady state occurs in the TA population. One of the most common methods to identify stem cells is to search for slowcycling cells by labeling their DNA. A pulse of bromodeoxyuridine (BrdU) mostly labels TA cells. Long-term BrdU labeling is thought to mark stem cells that retain the label for an extended period as a result of slow turnover. An adequate labeling intensity and a suitable washout period of the TA and terminal differentiation compartments thus will result in socalled label-retaining cells (LRC), believed to represent the stem cell compartment. Using this method, slow-cycling stem cells have been identified in several tissues, including skin (5), cornea (6), intestine (7), lung (8) , and prostate (9) , and were shown to be involved in tissue regeneration.
In the kidney, renal epithelial tubular cells are known to proliferate actively and differentiate to reconstitute tubular epithelium during the recovery from a variety of insults (10).
To date, several studies have suggested the existence of renal progenitor-like tubular cells (11) (12) (13) . In response to renal injury, numerous tubular cells proliferate and some express a mesenchymal marker, vimentin, suggesting that they are of an immature phenotype (13) . These proliferating cells also express a transcription factor critical for kidney development, Pax-2 (11, 12) . Considering that regeneration processes may recapitulate developmental paradigms to restore organ or tissue function, it is possible that these cells are renal progenitor-like tubular cells. However, most of these cells seem to represent TA cells that replace damaged cells, because they have a high potential to proliferate. Renal stem cells in adult kidney have not been identified definitively. The present study demonstrated the existence of LRC in tubular cells of normal rat kidneys. During the recovery after renal ischemia, LRC underwent cell division, and most of them became positive for proliferating cell nuclear antigen (PCNA). At an early phase of tubular regeneration, descendants of LRC expressed vimentin and eventually became positive for Ecadherin. These findings suggested that descendants of LRC with an immature phenotype actively proliferate and consequently differentiate into epithelial tubular cells during tubular regeneration. These data will provide new insights into the mechanism of tubular regeneration after a variety of insults.
Materials and Methods

Materials
Polyclonal mouse anti-vimentin antibody and polyclonal rabbit anti-cytokeratin antibody were obtained from NEO MARKERS (Fremont, CA) and DAKO (Glostrup, Denmark), respectively. Polyclonal rabbit anti-Tamm Horsfall glycoprotein was obtained from Biomed-ical Technologies (Stoughton, MA). FITC-labeled Lotus tetragonolobus agglutinin and TRITC-labeled Dolichos Biflorus agglutinin were purchased from Vector Laboratories (Burlingame, CA) and EY Laboratories (San Mateo, CA), respectively. Monoclonal mouse or rat anti-BrdU antibody was obtained from Amersham Bioscience (Tokyo, Japan) and AbCam (Cambridge, UK), respectively. Polyclonal rabbit anti-E-cadherin antibody, goat anti-human PCNA antibody, and goat anti-aquaporin-2 antibody were obtained from Santa Cruz Biotechnology (Santa Cruz, CA).
BrdU Labeling
Male Wistar rats that weighed 200 to 230 g were obtained from Nihon SLC, (Hamamatsu, Japan). LRC were detected by BrdU labeling. BrdU (100 mg/kg), an analogue of thymidine, was injected intraperitoneally into normal rats daily for 1 wk. After 2 wk, rats were killed, and the kidneys were removed and embedded in paraffin. At this dose, the animals seemed healthy, with normal kidney histology during the entire course of the experiments. Four-micrometer sections were immunostained using a cell proliferation kit (Amersham, Tokyo, Japan) according to the manufacturer's instructions and counterstained with periodic acid-Schiff or hematoxylin.
Ischemia/Reperfusion Injury
Ischemia/reperfusion injury was performed as described previously (14) . Briefly, under anesthesia with pentobarbital sodium (30 mg/kg body wt), renal ischemia was induced by clamping both renal arteries for 45 min using a nontraumatic vascular clamp. After removal of the clamp to allow reperfusion for the indicated periods, rats were killed and the kidneys were removed for histologic analysis. Sham operations were performed in a similar manner, except without clamping the renal arteries.
Immunohistochemistry
Immunohistochemical analysis via an avidin-biotin coupling immunoperoxidase technique was performed using a Vectastain Elite ABC kit (Vector Laboratories) according to the manufacturer's instructions (15) . Briefly, kidneys were fixed in 4% formaldehyde and embedded in paraffin. Four-micrometer sections were deparaffinized and rehydrated in a routine manner. After inactivation of endogenous peroxidase with 1% metaperiodic acid in PBS for 10 min at room temperature, sections were preincubated with normal goat/rabbit serum for 1 h. Sections were then incubated with primary antibody for 2 h, washed with PBS, and reacted with a biotinylated rabbit anti-goat IgG or a biotinylated goat anti-mouse IgG for 1 h. After washing with PBS, sections were reacted with Vectastain Elite ABC Reagent. Antibody was detected with diaminobenzidine tetrahydrochloride in PBS, and sections were counterstained with hematoxylin. For immunohistochemical controls, the primary antibody was replaced with normal goat/rabbit serum, which did not show positive staining, thus confirming specificity. In a separate experiment, indirect fluorescence immunostaining was also performed as described previously (12) .
Quantification of BrdU and/or PCNA-Positive Cells
Quantitative analysis of BrdU-positive cells was performed by counting the positive nuclei in tubular cells from five randomly selected fields of the outer medulla under a light microscope at ϫ200. The average of the five determinants was calculated and was recorded as the number of BrdU-positive cells per square micrometer. The results were expressed as the proliferation index. Quantification of PCNA-positive cells was performed in a similar manner. In case of indirect fluorescence staining, quantification of BrdUϩ/PCNAϩ, BrdUϩ/PCNAϪ, and BrdUϪ/PCNAϩ cells was performed by counting positive nuclei from five randomly selected fields of the kidneys under a fluorescence microscope at ϫ400. The results were expressed as a percentage of total cells of five sections per rat. The average of five determinations was calculated (15) .
Statistical Analysis
The differences between means were compared by t test, with P Ͻ 0.05 considered significant.
Results
Existence of LRC in Normal Rat Kidneys
To localize slow-cycling cells in normal rat kidneys, we performed a series of kinetic analyses and identified them as the LRC. BrdU was injected intraperitoneally into normal rats daily for 7 d, and kidneys were removed immediately after the final administration. As shown in Figure 1A , BrdU-positive cells were observed in normal rat kidney. BrdU-positive cells were localized in tubuli ( Figure 1B ), glomeruli ( Figure 1C) , and peritubular capillaries ( Figure 1D ). For excluding rapidly cycling cells, BrdU was injected intraperitoneally into normal rats daily for 7 d and kidneys were removed after a 2-wk chase period. As shown in Figure 1E , LRC were still detectable scattered in proximal and distal tubuli. Of particular interest was that most of these were adjacent to capillary endothelial cells ( Figure 1F ). LRC were also localized in collecting ducts but were not detected in glomeruli and capillary vessels (data not shown). To examine further the distribution of LRC in the kidney, we performed double staining of BrdU and several markers for nephron segment (Figure 2) . Most of the LRC were co-localized with Lotus tetragonolobus agglutinin, a lectin that labels specifically proximal tubules. However, few LRC were co-localized with Tamm Horsfall glycoprotein, which is expressed in the thick ascending limb of Henle and distal tubules. Some of the LRC were also present in collecting ducts that stained positive with Dolichos Biflorus agglutinin but were undetectable in aquaporin-2-expressing cells. These results indicate that LRC are present in renal epithelial tubular cells of normal rat kidneys.
Increase in the Number of LRC in the Kidneys after Renal Ischemia
We next examined the involvement of LRC in tubular regeneration. BrdU was injected intraperitoneally into normal rats for 7 d. After a 2-wk chase period, we induced ischemia/ reperfusion injury in these rats, and kidneys were removed at the indicated periods. There was no significant difference in the number of LRC between normal ( Figure 3A ) and shamoperated kidneys ( Figure 3B ). As shown in Figure 3C , LRC were abundantly detected in the ischemic kidney at 24 h after reperfusion. It should be stressed that many BrdU-positive cells were found in clusters of two cells ( Figure 3D ). Quantitative analysis showed that the number of LRC increased by twofold at 24 h after reperfusion ( Figure 3E ).
Descendents of LRC Function as TA Cells during Tubular Regeneration
As an alternative approach to detect proliferating cells in the kidney after renal ischemia, we examined the localization of tubular cells positive for PCNA, which specifically recognizes the early G1 and S phases of the cell cycle. There were few PCNA-positive cells in normal ( Figure 4A ) and sham-operated kidneys ( Figure 4D) . In contrast, a number of PCNA-positive cells were observed among tubular cells in ischemic kidneys at 12 h after reperfusion ( Figure 4B ). At 24 h after reperfusion, numerous PCNA-positive cells were observed in the outer medulla of ischemic kidneys ( Figure 4C ). Quantitative analysis showed a significant increase in the number of PCNA-positive cells in the kidney after renal ischemia ( Figure 4E ).
We then compared the localization of LRC with that of PCNA-positive cells in the kidney after renal ischemia by double immunostaining. LRC were not positive for PCNA in normal kidneys and ischemic kidneys at 12 h after reperfusion (data not shown). However, at 24 h after reperfusion, more than two thirds of LRC were positive for PCNA ( Figure 5 , A to E). In contrast, very few PCNA-positive cells lacking BrdU labeling were observed ( Figure 5F ).
To investigate further the cell kinetics of LRC after the proliferation phase, we investigated the existence of LRC in ischemic kidneys at 10 d after reperfusion. At this time point, PCNA-positive cells were no longer detectable in ischemic kidneys (data not shown), indicating the completion of the proliferation phase. As shown in Figure 6A , numerous LRC were still present in sham-operated kidneys. Quantitative analysis revealed that there was no significant difference in the number of LRC between normal and sham-operated kidneys ( Figure 6C ). LRC were also detectable in ischemic kidneys at 10 d after reperfusion, although their numbers were relatively small when compared with those of normal and sham-operated kidney ( Figure 6 , B and C).
Immature Mesenchymal Phenotype of Descendants of LRC during Tubular Regeneration
To characterize the phenotype of LRC, we examined the expression of a mesenchymal marker, vimentin, in the kidneys of rats with BrdU labeling after ischemia/reperfusion injury. In normal kidneys, neither LRC nor nonlabeled tubular cells expressed vimentin (data not shown). In contrast, among the pairs of LRC found in ischemic kidneys at 18 h after reperfusion, one of each pair expressed vimentin, whereas the other did not (Figure 7, a to d) . At 24 h after reperfusion, vimentin was expressed in cells weakly positive for BrdU but not in those strongly labeled (Figure 7 , e to h). At 10 d after reperfusion, vimentin was broadly expressed in tubular cells in the outer medulla of ischemic kidneys (Figure 7j ). Some scattered tubular cells retained BrdU staining in ischemic kidneys at 10 d after reperfusion (Figure 7i) . However, at this time point, LRC barely expressed vimentin, although they were adjacent to vimentin-expressing cells (Figure 7k ).
Differentiation of Descendants of LRC after Proliferation Phase
To investigate further the differentiation of LRC and their descendants, we examined the expression of an epithelial marker, E-cadherin, in ischemic kidneys at 10 d after reperfusion. E-cadherin was expressed in the plasma membrane of some tubular cells in ischemic kidneys at 10 d after reperfusion ( Figure 7 , n and r) but not in normal kidneys (data not shown). Similar to the localization of vimentin, E-cadherin was also expressed by cells lying close to LRC (Figure 7 , m to p). LRC surrounded by E-cadherin-expressing cells did not express E-cadherin. Moreover, the expression of E-cadherin and vimentin seems continuous but exclusive ( Figure 7 , q to t), indicating the various differentiation stages of regenerating cells.
Discussion
In the present study, we demonstrated that BrdU was incorporated into tubular cells, mesangial cells, and capillary endothelial cells in the kidneys of normal rats after daily injection of BrdU for 1 wk. In addition, after a 2-wk chase period, BrdU-positive cells were no longer detectable in glomeruli or capillary vessels in these rats (Figure 1 ), suggesting that these cells have a rapid turnover. However, PCNA-positive cells were not detected in glomeruli or capillary blood vessels in normal rat kidneys (data not shown), indicating that resident cells constituting glomeruli or capillary vessels are quiescent. Considering that proliferating cells are generally detectable by PCNA staining when cell turnover is rapid and PCNA is adequately concentrated into nuclei, it is possible that BrdUpositive mesangial cells or capillary endothelial cells are rapidly cycling but the content of PCNA in their nuclei is not enough to detect them by PCNA staining. In the present study, we cannot distinguish whether BrdU-positive mesangial cells or capillary endothelial cells are resident renal cells or extrarenal cells, but there is some suggestive evidence about their origin. In the adult, tissue regeneration was thought to occur through the action of tissue-restricted stem cells. However, it is now believed that stem cells from one organ system can develop into differentiated cells within another organ system (16) . Consistent with this notion, it has been reported that bone marrow-derived progenitor cells could be substituted for mesangial cells (17) (18) (19) or vascular endothelial cells (20, 21) . Therefore, the possibility cannot be denied that BrdU-positive mesangial cells or capillary endothelial cells are derived from bone marrow. Further study will be needed to clarify this issue. In contrast to mesangial and endothelial cells, LRC are clearly detected in renal tubules (Figures 1 and 2) . Recent studies showed that renal tubular cells are substituted by bone marrow-derived cells under nonphysiologic conditions including renal (22, 23) or bone marrow (24) transplantations. Therefore, it is also unknown yet whether LRC represent resident tubular cells or cells derived from bone marrow. Nevertheless, our current study demonstrated for the first time that LRC were present in renal tubuli of normal rat kidneys.
Among our results was the novel finding that the number of LRC significantly increased in the kidney after renal ischemia Figure 2 . Distribution of LRC in nephron segments of normal rat kidneys. BrdU was injected intraperitoneally into normal rats once a day for 7 d, and kidneys were removed after a 2-wk chase period. Localization of Lotus tetragonolobus agglutinin, Tamm Horsfall glycoprotein, Dolichos Biflorus agglutinin, aquaporin-2, and BrdU were examined by indirect fluorescence staining. DAPI (blue). Bars ϭ 50 m.
( Figure 3) . At 24 h after reperfusion, there were numerous PCNA-positive tubular cells in the outer medulla of ischemic kidneys (Figure 4) , indicating that renal epithelial tubular cells have the potential to proliferate in response to ischemic injury. Importantly, most PCNA-positive cells were labeled with BrdU as well ( Figure 5 ). In contrast, PCNA-positive but BrdU- negative cells were rarely observed ( Figure 5 ). Collectively, these results indicate that the majority of proliferating cells involved in recovery processes in the kidney after renal ischemia are derived from LRC.
Stem cells are a self-maintaining population. During tissue regeneration, stem cells are considered to divide asymmetrically into stem cells and transit-amplifying cells, the latter of which vigorously proliferate, differentiate, and finally reconstitute part of the tissue (25) . At each asymmetric cell division, stem cells are postulated to retain selectively a set of chromosomes that contain old template DNA strands (26) . In the present study, we observed that the BrdU staining frequently displayed uneven distribution (Figure 7) . Furthermore, at 10 d after reperfusion, when tubular cells are presumed to have completed multiple cells divisions, some LRC were still clearly detectable (Figures 6 and 7) . At present, we cannot exclude the possibility that some LRC, which did not divide after renal injury, remain as BrdU-positive cells. However, if this concept of asymmetrical cell division might be applicable to the dynamics of LRC in regeneration processes of the kidney, then the present findings suggest a difference in nuclear BrdU content between daughter cells as a result of asymmetric cell division and raise the possibility that LRC are programmed to divide asymmetrically during tubular regeneration, thereby retaining the BrdU staining for longer periods. On the basis of this assumption, we regarded tubular cells that are weakly positive for BrdU and are localized proximal to cells strongly positive for BrdU as descendants of LRC. Descendants of LRC expressed vimentin during the early phases of tubular regeneration ( Figure 7 ). In addition, LRC were surrounded by vimentin-expressing cells after the cell proliferation phase had subsided (Figure 7) . At this time, vimentin-expressing cells were no longer labeled with BrdU, presumably because multiple cell divisions caused BrdU staining to fade. We also observed that E-cadherin was expressed in tubular cells localized near the LRC in ischemic kidneys at 10 d after reperfusion (Figure 7) , suggesting the eventual differentiation of descendants to epithelial cells. Taken together, it is possible that LRC undergo asymmetrical cell division and that their descendants acquire immature mesenchymal phenotype as well as a high potential to proliferate and differentiate into epithelial tubular cells and function as TA cells during tubular regeneration.
LRC phenotype remains unknown at present. Morphologically, LRC were localized in mature tubular cells (Figure 1 ) and were co-localized with some markers for nephron segment (Figure 2 ), suggesting that LRC are in a differentiated state. However, these findings cannot totally exclude the possibility that LRC are undifferentiated. Although there might be no morphologic difference between LRC and other tubular cells except the degree of DNA synthesis progression, we consider that there must be some differentiation markers that express in all epithelial tubular cells but LRC. Such specific markers for LRC may be important molecules involved in multiple cellular processes during differentiation such as cytoskeletal reorganization, cell adhesion, and epithelial polarization or may also be physiologically functional proteins, for example, amino acid or ion transport. Identification of selective markers that are positive or negative in LRC will be requisite for us to isolate LRC from tubular cells of normal kidneys and to characterize the mode of cell growth and differentiation of LRC in vitro. Renal epithelial tubular cells are thought to express an epithelial marker, E-cadherin, in a steady state. However, we could detect E-cadherin in regenerating kidneys after ischemia/reperfusion injury but not in normal rat kidneys. This may be because its expression level is too low to detect in normal kidney or poor sensitivity of antibody used.
In extensively studied tissues such as the epidermis (5,27,28), intestinal epithelium (7, 29) , and cornea (6, 30) , LRC reside in specialized and generally well-protected niches that are spatially proximal to their more differentiated progeny. These niches are believed to be a subset of tissue cells and extracellular substrates that can indefinitely house one or more stem cells and control their self-renewal and progeny production (3, 4) . We demonstrated here that most LRC are associated with capillary endothelial cells (Figure 1) . Our recent studies demonstrated that activin A, a member of the TGF-␤ superfamily, inhibited, whereas follistatin, an antagonist of activin A, promoted the proliferation of renal epithelial progenitor-like cells during tubular regeneration (12, 14, 31) . Because vascular endothelial cells are known to produce activin A (32), it is possible that activin A produced by capillary endothelial cells play a role in maintaining LRC in a quiescent state.
In summary, we demonstrated the presence of LRC in normal rat kidney. During tubular regeneration, LRC act as a source of regenerating cells that have an immature phenotype, actively proliferate, and consequently differentiate into epithelial tubular cells. From the aspect of regenerative medicine, identification of the factors regulating cell growth and differentiation of LRC is likely to be a very important issue, and such factors may become effective therapeutic agents that accelerate tubular regeneration. Transplantation of LRC into damaged kidneys may also provide a new therapeutic approach for kidney disease in the future, provided that a technique for isolating as well as propagating LRC in vitro is established. At all events, the present results will provide new insights into the mechanism of tubular regeneration after injury.
